Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8281830 | 1.00 | ALDH1A1 (0.64) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL8049390 | 0.87 | ALDH1A1 (0.77) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL11870023 | 0.83 | KMT2A (0.60) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL20183041 | 0.83 | KMT2A (0.60) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL20183040 | 0.83 | KMT2A (0.60) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL1520728 | 0.83 | KMT2A (0.49) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL1520939 | 0.83 | KMT2A (0.49) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL1521030 | 0.83 | KMT2A (0.49) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL13649427 | 0.81 | ALDH1A1 (0.62) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 | |
| SCHEMBL13485414 | 0.81 | CHRM1 (0.51) | ALDH1A1L3MBTL1GAAKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115697059-A | Active compound combinations | 拜耳公司 | 2023-02-03 | — | — | CN | claimed |
| WO-2025132148-A1 | ADJUVANT COMPOSITIONS FOR AGROCHEMICAL APPLICATIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025108865-A1 | HERBICIDAL COMPOSITIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-30 | — | — | WO | disclosed |
| CN-114269720-B | Acetyl-coa synthetase short chain2(ACSS2) Small molecule inhibitors of (a) | 库拉德夫制药私人有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-114466836-A | Solvates of abscisic acid and liquid compositions containing abscisic acid | 科莱恩国际有限公司 | 2022-05-10 | — | — | CN | disclosed |
| CN-106035349-A | Agricultural composition for preventing and removing harmful organisms and application method thereof | 日本农药株式会社 | 2016-10-26 | — | — | CN | disclosed |
| US-20100056497-A1 | AMIDE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD (JP) | 2010-03-04 | — | — | US | disclosed |
| US-20100056497-A1 | AMIDE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD (JP) | 2010-03-04 | — | — | US | disclosed |
| WO-2009124962-A2 | SULFONAMIDES | MERCK SERONO S.A. (CH) | 2009-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056497-A1 | AMIDE DERIVATIVE | REN, AGTR1, AGTR2 | ALDH1A1 348/4885L3MBTL1 3531/4885GAA 1558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.